Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene (original) (raw)

References

  1. Pepys, M.B., Amyloidosis. in Samter's Immunologic Diseases. (eds. Frank, M.M., Austen, K.F., Claman, H.N. & Unanue, E.R.) 637–655 (Little, Brown and Co., Boston, 1994).
    Google Scholar
  2. Glenner, G.G. Amyloid deposits and amyloidosis — the β-fibrilloses. I. N. Engl. j. Med. 302, 1283–1292 (1980).
    Article CAS Google Scholar
  3. Glenner, G.G. Amyloid deposits and amyloidosis — the β-fibrilloses. II. N. Engl. J. Med. 302, 1333–1 343 (1980).
    Article CAS Google Scholar
  4. Blake, C.C.F. & Serpell, L.C. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix. Structure 4, 989–998 (1996).
    Article CAS Google Scholar
  5. Pepys, M.B. et al. Amyloid P component. A critical review. Amyloid: Int. J. Exp. Clin. Invest. (in the press).
  6. Hawkins, P.N. & Pepys, M.B. Imaging amyloidosis with radiolabelled SAP. Eur. J. Nucl. Med. 22, 595–599 (1995).
    Article CAS Google Scholar
  7. Hind, C.R.K., Collins, P.M., Caspi, D., Baltz, M.L. & Pepys, M.B. Specific chemical dissociation of fibrillar and non-fibrillar components of amyloid deposits. Lancet ii, 376–378 (1984).
    Article Google Scholar
  8. Pepys, M.B. Amyloid P component: Structure and properties. in Amyloidosis. (eds. Marrink, J. & van Rijswijk, M.H.) 43–50 (Martinus Nijhoff, Dordrecht, the Netherlands, 1986).
    Chapter Google Scholar
  9. Pepys, M.B. et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. USA 91, 5602–5606 (1994).
    Article CAS Google Scholar
  10. Tennent, G.A., Lovat, L.B. & Pepys, M.B. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer's disease and systemic amyloidosis. Proc. Natl. Acad. Sci. USA 92, 4299–4303 (1995).
    Article CAS Google Scholar
  11. Hawkins, P.N., Tennent, G.A., Woo, P. & Pepys, M.B. Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis. Clin. Exp. Immunol. 84, 308–316 (1991).
    Article CAS Google Scholar
  12. Kinoshita, C.M. et al. A protease-sensitive site in the proposed Ca2+-binding region of human serum amyloid P component and other pentraxins. Protein Sci. 1, 700–709 (1992).
    Article CAS Google Scholar
  13. Hutchinson, W.L., Noble, G.E., Hawkins, P.N. & Pepys, M.B. The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo . J. Clin. Invest. 94, 1390–1396 (1994).
    Article CAS Google Scholar
  14. Nelson, S.R. et al. Serum amyloid P component in chronic renal failure and dialysis. Clin. Chim. Acta 200, 191–200 (1991).
    Article CAS Google Scholar
  15. Cathcart, E.S., Wollheim, F.A. & Cohen, A.S. Immunoassay of P-component in amyloidotic sera. Proc. Soc. Exp. Biol. Med. 125, 1123–1125 (1967).
    Article CAS Google Scholar
  16. Hawkins, P.N., Wootton, R. & Pepys, M.B. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis. J. Clin. Invest. 86, 1862–1869 (1990).
    Article CAS Google Scholar
  17. Baltz, M.L. et al. Differences in the acute phase responses of serum amyloid P component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and resistant mouse strains. Clin. Exp. Immunol. 39, 355–360 (1980).
    CAS PubMed PubMed Central Google Scholar
  18. Coe, J.E. & Ross, M.J. Amyloidosis and female protein in the Syrian hamster: Concurrent regulation by sex hormones. J. Exp. Med. 171, 1257–1267 (1990).
    Article CAS Google Scholar
  19. Snel, F. et al. Experimental amyloidosis in the hamster: Correlation between hamster female protein levels and amyloid deposition. Clin. Exp. Immunol. 76, 296–300 (1989).
    CAS PubMed PubMed Central Google Scholar
  20. Janigan, D.T. Experimental amyloidosis: Studies with a modified casein method, casein hydrolysate and gelatin. Am. J. Pathol. 47, 159–171 (1965).
    CAS PubMed PubMed Central Google Scholar
  21. Benson, M.D., Scheinberg, M.A., Shirahama, T., Cathcart, E.S. & Skinner, M. Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J. Clin. Invest. 59, 412–417 (1977).
    Article CAS Google Scholar
  22. Caspi, D. et al. Imaging of experimental amyloidosis with 131l-serum amyloid P component. Arthritis Rheum. 30, 1303–1306 (1987).
    Article CAS Google Scholar
  23. Hawkins, P.N., Myers, M.J., Epenetos, A.A., Caspi, D. & Pepys, M.B. Specific localization and imaging of amyloid deposits in vivo using 123l-labeled serum amyloid P component. J. Exp. Med. 167, 903–913 (1988).
    Article CAS Google Scholar
  24. Vigushin, D.M., Pepys, M.B. & Hawkins, P.N. Comparison of histology with SAP scintigraphy for evaluation of amyloidosis. in Amyloid and Amyloidosis 1993. (eds. Kisilevsky, R. et al.) 685–687 (Parthenon Publishing, Pearl River, NY, 1994).
    Google Scholar
  25. Tan, S.Y., Pepys, M.B. & Hawkins, P.N. Treatment of amyloidosis. Am. J. Kidney Dis. 26, 267–285 (1995).
    Article CAS Google Scholar
  26. Kisilevsky, R., Gruys, E. & Shirahama, T. Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity? Amyloid: Int. J. Exp. Clin. Invest. 2, 128–133 (1995).
    Article Google Scholar
  27. Ganowiak, K., Hultman, P., Engstrom, U., Gustavsson, A. & Westermark, P. Fibrils from synthetic amyloid-related peptides enhance development of experimental AA amyloidosis in mice. Biochem. Biophys. Res. Commun. 199, 306–312 (1994).
    Article CAS Google Scholar
  28. Booth, D.R. et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385, 787–793 (1997).
    Article CAS Google Scholar
  29. Hawkins, P.N. & Pepys, M.B. A primed state exists in vivo following histological regression of amyloidosis. Clin. Exp. Immunol. 81, 325–328 (1990).
    Article CAS Google Scholar
  30. Hawkins, P.N. et al. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis. Arthritis Rheum. 36, 842–851 (1993).
    Article CAS Google Scholar
  31. Coria, F. et al. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab. Invest. 58, 454–458 (1988).
    CAS Google Scholar
  32. Duong, T., Pommier, E.C. & Scheibel, A.B. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol. 78, 429–437 (1989).
    Article CAS Google Scholar
  33. Kalaria, R.N., Galloway, P.G. & Perry, G. Widespread serum amyloid P immunore-activity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders. Neuropathol. Appl. Neurobiol. 17, 189–201 (1991).
    Article CAS Google Scholar
  34. Kitamoto, T., Tateishi, J., Hikita, K., Nagara, H. & Takeshita, I. A new method to classify amyloid fibril proteins. Acta Neuropathol. 67, 272–278 (1985).
    Article CAS Google Scholar
  35. Fricker, J. From mechanisms to drugs in Alzheimer's disease. The Lancet 349, 480 (1997).
    Article CAS Google Scholar
  36. Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523–527 (1995).
    Article CAS Google Scholar
  37. Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99–102 (1996).
    Article CAS Google Scholar
  38. Collinge, J. et al. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 378, 779–783 (1995).
    Article CAS Google Scholar
  39. Axelrad, M.A., Kisilevsky, R., Willmer, J., Chen, S.J. & Skinner, M. Further characterisation of amyloid-enhancing factor. Lab. Invest. 47, 139–146 (1982).
    CAS PubMed Google Scholar
  40. Pepys, M.B., Baltz, M., Comer, K., Davies, A.J.S. & Doenhoff, M. Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 278, 259–261 (1979).
    Article CAS Google Scholar
  41. Pepys, M.B. Isolation of serum amyloid P component (protein SAP) in the mouse. Immunology 37, 637–641 (1979).
    CAS PubMed PubMed Central Google Scholar

Download references